IB Acquisition Corp（IBAC）股票分析

AI 分析 of IB Acquisition Corp (IBAC)

賣出

IB Acquisition Corp is not a good buy right now due to significant financial struggles and negative momentum. The current price is $10.81, with a 52-week high of $11.64, indicating it is near the lower end of its range. The RSI is at 20.283, which suggests it is oversold, but this could indicate a continued downward trend rather than a buying opportunity. Additionally, the company has reported negative net income in the last three quarters, with a loss of $639,866 in Q2 2026, raising concerns about its financial health.

估值指標

IB Acquisition Corp（IBAC）目前預期本益比為 0.00，5 年平均預期本益比為 0.00。

預期本益比

嚴重低估

5 年均值 P/E

0.00

目前P/E

0.00

高估

0.00

低估

0.00

預期 EV/EBITDA

嚴重低估

5 年均值 EV/EBITDA

0.00

目前EV/EBITDA

0.00

高估

0.00

低估

0.00

預期股價營收比

合理

5 年均值 P/S

0.06

目前P/S

0.00

高估

0.83

低估

-0.72

Alphio AI 對 IBAC 的價格情境

情境價格取自當年最後一個月度預測區間。機率為固定的模型權重（25 / 50 / 25），不構成保證。

樂

樂觀

樂觀 · 25%IBAC

$11.75

情境價格

基

基準

基準 · 50%IBAC

$10.62

情境價格

悲

悲觀

悲觀 · 25%IBAC

$10.48

情境價格

IBAC 常見問題 —— 由 Alphio AI 解答

IB Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (the Business Combination). It intends to focus on pursuing an acquisition of or merger with high-growth companies in a number of industries including but not limited to fintech, healthcare and life sciences, sports and entertainment, and consumer goods. The Company anticipates targeting companies domiciled in North America, Europe and Asia, with an enterprise value of at least $500 million. The Company has neither engaged in any operations nor generated any revenues. It operates in the Financials sector.

IB Acquisition Corp is not a good buy right now due to significant financial struggles and negative momentum. The current price is $10.81, with a 52-week high of $11.64, indicating it is near the lower end of its range. The RSI is at 20.283, which suggests it is oversold, but this could indicate a continued downward trend rather than a buying opportunity. Additionally, the company has reported negative net income in the last three quarters, with a loss of $639,866 in Q2 2026, raising concerns about its financial health.